The global market for Assisted Reproductive Technology Market is on a steady, robust upward trajectory. According to the latest report from Market Research Future (MRFR), the ART market was valued at USD 27.51 billion in 2024. Over the forecast period from 2025 to 2035, the market is projected to grow to USD 45.02 billion by 2035, reflecting a compound annual growth rate (CAGR) of 4.58 %

What’s Driving This Growth?

Several factors are fueling this expansion:

  • Increasing infertility rates — shifting lifestyle patterns, delayed parenthood, and environmental or health factors have contributed to a growing need for fertility solutions.

  • Broader social acceptance of fertility treatments and assisted reproduction, reducing stigma and encouraging more couples to seek help.

  • Technological advances — innovations such as cryopreservation (freezing embryos/eggs for future use), preimplantation genetic diagnosis, and emerging methods like assisted hatching are improving success rates and outcomes.

  • Regional growth especially in Asia-Pacific — while North America remains the largest regional market, Asia-Pacific is emerging as the fastest-growing region, thanks to rising investments in fertility clinics, growing awareness, and changing patient demographics.

Market Segmentation: Where the Demand Is

The ART market can be segmented along several dimensions:

  • By Procedure Type: Including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Transfer, Egg Donation, Sperm Donation. Among these, IVF continues to dominate, while ICSI and related procedures are seeing rapid growth.

  • By Technology: Techniques such as Cryopreservation, Preimplantation Genetic Diagnosis (PGD), and Assisted Hatching — with cryopreservation being widely used to preserve embryos or eggs for future fertility attempts.

  • By Product Type: Reagents & consumables (used in lab procedures) hold the largest share. Equipment (labs, incubators, microscopes, etc.) are also increasingly important as clinics invest in advanced infrastructure.

  • By End User: Fertility clinics, hospitals, and — to a growing extent — home‑care/follow-up services.

What’s New: Trends Reshaping the ART Market

  • Digitalization and Tele‑health: Clinics and fertility centers are increasingly adopting digital platforms to offer remote consultations, patient management, and follow‑ups — improving accessibility for patients.

  • Personalized Medicine & Genetic Screening: There is a rising focus on individualized fertility care — including genetic screening of embryos (PGD/PGT) to increase success rates and reduce risk of genetic disorders.

  • Sustainability and Supply Chain Reliability: As demand rises globally, many players are focusing on sustainable lab practices, reliable supply of reagents and consumables, and robust logistics to ensure availability across regions.

  • Affordability & Accessibility Measures: Some fertility centers are launching financing options or subsidized programs to lower the cost barrier for patients — which could widen the patient base significantly.

Outlook: What to Expect Through 2035 and Beyond

With projected growth to over USD 45 billion by 2035, the ART market seems poised for sustained expansion. Key opportunities lie in:

  • AI‑driven embryo selection and diagnostics — helping improve success rates and personalize treatments.

  • Expansion in emerging markets, particularly in Asia‑Pacific, as awareness, socio‑economic conditions, and healthcare infrastructure improve.

  • Integration of tele‑medicine and remote patient support, making fertility treatments more accessible — especially for patients in regions with fewer specialized clinics.

However, the market will also need to navigate challenges such as regulatory and ethical concerns, costs, and ensuring equitable access across income levels and regions.

 FAQ 

Q1. What is the current size of the global Assisted Reproductive Technology (ART) market?
A1. According to the latest analysis from Market Research Future, the global ART market was valued at approximately USD 27.51 billion in 2024.

Q2. What’s driving growth in the ART market, and which technologies are leading the way?
A2. Growth is driven by rising infertility rates, shifting societal norms (delayed parenthood), broader acceptance of fertility treatments, and technological advances. Leading technologies include cryopreservation (freezing eggs/embryos), preimplantation genetic diagnosis (PGD/PGT), and procedures like In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI).